Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Promoter Methylation and Low Placental Expression of Metalloproteinase (MMP)-9, Human Leukocyte Antigen (HLA)-G, Vascular Endothelial Growth Factor (VEGF), and Highly Soluble Endoglin (sEng) as Risk Factors for Preeclampsia

The Indonesian Biomedical Journal · Vol. 18 No. 1 (2026) · hlm. 67–76

DOI
10.18585/inabj.v18i1.3921
ISSN
2085-3297, 2355-9179
Terbit
2026-02-23
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Dysregulated expressions of metalloproteinase (MMP)-9, human leucocyte antigen (HLA)-G, vascular endothelial growth factor (VEGF), and soluble endoglin (sEng) reflect impaired angiogenesis, immune tolerance, endothelial function, and trophoblast invasion that characterize abnormal placental development in preeclamptic (PE) pregnancies. However, the role of promoter methylation of these markers in linking the pathways to altered protein expression remains unclear. Hence, this study compared promoter methylation and placental expression of MMP-9, HLA-G, VEGF, and sEng between women with PE and normotensive pregnancies, and evaluate their diagnostic performance as potential biomarkers.METHODS: This case–control study included 30 women with PE and 30 controls. Placental tissue samples were collected within 15 minutes postpartum. Placental promoter methylation was assessed using methylation-specific polymerase chain reaction (PCR), and protein expression was measured using enzyme-linked immunosorbent assay (ELISA). Group differences were analyzed, diagnostic accuracy was evaluated using receiver operating characteristic (ROC) curves, and associations were expressed as adjusted odds ratios (AOR).RESULTS: Compared with controls, placentas from women with PE significantly showed higher methylation of HLA-G (58.9% vs. 37.3%) and sEng (6.7% vs. 4.1%), and lower methylation of VEGF (30.4% vs. 48.1%) and MMP-9 (36.1% vs. 44.9%). Expression of MMP-9, HLA-G, and VEGF was significantly reduced, while sEng expression was increased in PE. Multivariate analysis identified HLA-G hypermethylation (AOR 5.36), VEGF hypomethylation (AOR 8.55), sEng methylation (AOR 4.57), low expression of MMP-9, HLA-G, and VEGF, and high sEng expression (AOR 4.77) as independent predictors of PE. sEng expression demonstrated the best discrimination (AUC 0.835), followed by sEng methylation (AUC 0.785) and HLA-G methylation (AUC 0.774).CONCLUSION: PE is associated with distinct placental methylation–expression alterations, with sEng- and HLA-G–related markers showing the strongest diagnostic value.KEYWORDS: preeclampsia, DNA methylation, angiogenesis, MMP-9, HLA-G, sEng, placenta, epigenetics

Kata kunci

Jaringan kolaborasi para penulis

37 penulis · 152 tautan kepenulisan bersama · 19 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Udayana University
  • National Cheng Kung University
  • Universitas Pendidikan Ganesha
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Anom SuardikaUdayana University3
William WilliamUdayana University2
I Gede Mega PutraAfiliasi tidak diketahui2
Evert Solomon PangkahilaAfiliasi tidak diketahui2
Vidya Saraswati Putri DuarsaUdayana University2
I Made BaktaUdayana University1
Dyah Paramita DuarsaAfiliasi tidak diketahui1
Luh Seri AniUdayana University1
Luh MertasariUniversitas Pendidikan Ganesha1
Ni Nengah Dwi FatmawatiUdayana University1
Arresta Vitasatria SuastikaUdayana University1
I Gde Raka WidianaUdayana University1
Ketut SuastikaUdayana University1
I Nengah SujayaUdayana University1
I Made JawiUdayana University1
Ni Nyoman Ayu DewiUdayana University1
Ni Gusti Ayu Manik ErmayantiUdayana University1
Endang Sri WidiyantiUdayana University1
I Gusti Ngurah Agung Satria WibawaUdayana University1
Divika SilvanaUdayana University1
Anak Agung Gede Raka BudayasaAfiliasi tidak diketahui1
H. Sunny SunNational Cheng Kung University1
Yen‐An TangNational Cheng Kung University1
Anak Agung Ngurah SubawaUdayana University1
I Wayan Gede Artawan Eka PutraUdayana University1
Anak Agung Wiradewi LestariUdayana University1
I Nyoman WandeUdayana University1
Ni Putu Sukma Sumantri PrabandariUdayana University1
Made SukmawatiUdayana University1
Ni Nyoman MahartiniUdayana University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Promoter Methylation and Low Placental Expression of Metalloproteinase (MMP)-9, Human Leukocyte Antigen (HLA)-G, Vascular Endothelial Growth Factor (VEGF), and Highly Soluble Endoglin (sEng) as Risk Factors for Preeclampsia</dc:title><dc:creator>Anak Agung Ngurah Jaya Kusuma</dc:creator><dc:creator>I Made Darmayasa</dc:creator><dc:creator>Ni Kadek Mulyantari</dc:creator><dc:creator>Ni Nyoman Wistya Tri Mayasari</dc:creator><dc:creator>Chatrine Sutandi</dc:creator><dc:creator>Godefridus Paolo Bay</dc:creator><dc:creator>Cokorda Gde Angga Ary Nugraha</dc:creator><dc:subject>preeclampsia</dc:subject><dc:subject>promoter methylation</dc:subject><dc:subject>HLA-G</dc:subject><dc:subject>MMP-9</dc:subject><dc:subject>vascular endothelial growth factor</dc:subject><dc:subject>soluble endoglin</dc:subject><dc:subject>placental gene expression</dc:subject><dc:subject>biomarkers</dc:subject><dc:subject>epigenetics</dc:subject><dc:subject>placental development</dc:subject><dc:subject>angiogenesis</dc:subject><dc:subject>endothelial function</dc:subject><dc:subject>trophoblast invasion</dc:subject><dc:subject>immune tolerance</dc:subject><dc:subject>risk factors</dc:subject><dc:subject>diagnostic accuracy</dc:subject><dc:subject>methylation-specific PCR</dc:subject><dc:subject>ELISA</dc:subject><dc:subject>receiver operating characteristic</dc:subject><dc:subject>normotensive pregnancy</dc:subject><dc:description xml:lang="en">BACKGROUND: Dysregulated expressions of metalloproteinase (MMP)-9, human leucocyte antigen (HLA)-G, vascular endothelial growth factor (VEGF), and soluble endoglin (sEng) reflect impaired angiogenesis, immune tolerance, endothelial function, and trophoblast invasion that characterize abnormal placental development in preeclamptic (PE) pregnancies. However, the role of promoter methylation of these markers in linking the pathways to altered protein expression remains unclear. Hence, this study compared promoter methylation and placental expression of MMP-9, HLA-G, VEGF, and sEng between women with PE and normotensive pregnancies, and evaluate their diagnostic performance as potential biomarkers.METHODS: This case–control study included 30 women with PE and 30 controls. Placental tissue samples were collected within 15 minutes postpartum. Placental promoter methylation was assessed using methylation-specific polymerase chain reaction (PCR), and protein expression was measured using enzyme-linked immunosorbent assay (ELISA). Group differences were analyzed, diagnostic accuracy was evaluated using receiver operating characteristic (ROC) curves, and associations were expressed as adjusted odds ratios (AOR).RESULTS: Compared with controls, placentas from women with PE significantly showed higher methylation of HLA-G (58.9% vs. 37.3%) and sEng (6.7% vs. 4.1%), and lower methylation of VEGF (30.4% vs. 48.1%) and MMP-9 (36.1% vs. 44.9%). Expression of MMP-9, HLA-G, and VEGF was significantly reduced, while sEng expression was increased in PE. Multivariate analysis identified HLA-G hypermethylation (AOR 5.36), VEGF hypomethylation (AOR 8.55), sEng methylation (AOR 4.57), low expression of MMP-9, HLA-G, and VEGF, and high sEng expression (AOR 4.77) as independent predictors of PE. sEng expression demonstrated the best discrimination (AUC 0.835), followed by sEng methylation (AUC 0.785) and HLA-G methylation (AUC 0.774).CONCLUSION: PE is associated with distinct placental methylation–expression alterations, with sEng- and HLA-G–related markers showing the strongest diagnostic value.KEYWORDS: preeclampsia, DNA methylation, angiogenesis, MMP-9, HLA-G, sEng, placenta, epigenetics</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2026-02-23</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v18i1.3921</dc:identifier><dc:identifier>10.18585/inabj.v18i1.3921</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 18 No 1 (2026); 67-76</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/3921/824</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>